Literature DB >> 6138578

Rapid metabolism of cyclosporin and prednisone in kidney transplant patient receiving tuberculostatic treatment.

E Langhoff, S Madsen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6138578     DOI: 10.1016/s0140-6736(83)91019-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  Effect of topical rifamycin SV treatment on cyclosporin A blood levels in a renal transplant recipient.

Authors:  E Renoult; J Hubert; P Trechot; D Hestin; M Kessler; J L'Hermite
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 2.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

3.  Interaction between cyclosporin A and phenobarbitone.

Authors:  H Carstensen; N Jacobsen; H Dieperink
Journal:  Br J Clin Pharmacol       Date:  1986-05       Impact factor: 4.335

4.  Extraction ratio of cyclosporine in a liver transplant patient with organ rejection.

Authors:  R Venkataramanan; R J Ptachcinski; G J Burckart; S Yang; T E Starzl
Journal:  J Pharm Sci       Date:  1985-08       Impact factor: 3.534

Review 5.  Pharmacokinetic drug interactions with rifampicin.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

6.  Resection of a pulmonary lesion after liver transplantation: report of a case.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Jun Nakajima; Yoji Kishi; Takashi Niiya; Junichi Kaneko; Masatoshi Makuuchi
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

7.  Lack of effect of spiramycin on cyclosporin pharmacokinetics.

Authors:  L Vernillet; P Bertault-Peres; Y Berland; J Barradas; A Durand; M Olmer
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

Review 8.  Clinical pharmacokinetics of cyclosporin.

Authors:  R J Ptachcinski; R Venkataramanan; G J Burckart
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

Review 9.  Practical aspects in the use of cyclosporin in paediatric nephrology.

Authors:  P F Hoyer; J Brodehl; J H Ehrich; G Offner
Journal:  Pediatr Nephrol       Date:  1991-09       Impact factor: 3.714

Review 10.  Clinically significant drug interactions with antituberculosis agents.

Authors:  J M Grange; P A Winstanley; P D Davies
Journal:  Drug Saf       Date:  1994-10       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.